 |
|
|
 |
|
Rituximab Reduced Disease Activity in MS Patients
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 "New and more effective treatments for MS are sorely needed, especially for people who do not adequately respond to current available medications. These data are also important, because they demonstrate that B-cells, which are the precursors of antibody-producing cells, play an essential role in mediating relapses of MS," Hauser said.
The studies were expected to be presented this week at the American Academy of Neurology's annual meeting, in Boston.
More information
Text Continues Below

The American Medical Association has more about MS.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/4/2007
|
 |

SOURCE: American Academy of Neurology, news release, May 1, 2007
|